Structures multidisciplinary tumor board case presentations with radiology, pathology, and treatment synthesis. Use when preparing tumor board cases, presenting MDT discussions, or documenting consensus recommendations.
Structures multidisciplinary tumor board case presentations with radiology, pathology, and treatment synthesis.
Multidisciplinary tumor boards (MTBs) are the standard of care for cancer treatment decision-making, required by CoC accreditation (Standard 5.1) for commission-accredited cancer programs. Evidence consistently shows that MTB review changes management in 20–50% of cases. CoC requires prospective case presentation for a minimum percentage of analytic cases, with documented attendance by representatives from surgery, medical oncology, radiation oncology, pathology, and diagnostic radiology.
Accurate tumor board documentation serves as the medical-legal record of consensus recommendations, supports prior authorization for treatment plans, and provides evidence of multidisciplinary care coordination for quality reporting. Poorly documented tumor boards fail CoC surveys, create liability gaps when treatment deviates from consensus, and lose institutional knowledge that could inform future cases.
Use the standardized tumor board presentation format:
A. Patient Demographics and History
B. Presenting Complaint and Diagnostic Workup
C. Pathology Summary
D. Radiology Summary
E. Staging
Every tumor board case must have an explicitly stated clinical question. Examples:
List each decision point separately. For each, document what information is needed from each specialty to inform the recommendation.
Record each specialist's contribution:
| Specialty | Expected Input |
|---|---|
| Pathology | Histologic confirmation, grade, biomarkers, additional staining if needed |
| Radiology | Image review findings, staging assessment, response evaluation |
| Surgical Oncology | Resectability assessment, operative approach, margin considerations |
| Medical Oncology | Systemic therapy recommendations, clinical trial options, molecular targets |
| Radiation Oncology | RT indication, field design, dose considerations, sequencing with systemic therapy |
| Genetics (if present) | Germline testing recommendations, hereditary syndrome assessment |
| Palliative Care (if present) | Symptom management needs, goals of care considerations |
Document verbatim quotes for key recommendations and any areas of disagreement between specialties.
The consensus recommendation must include: